Merck (NYSE:MRK) has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite ...

In a strategic move to enhance its manufacturing capabilities, Merck has inaugurated a new $1 billion vaccine manufacturing facility in Durham, North Carolina. This facility is part of Merck’s ...

In another development, Merck has opened a $1 billion vaccine manufacturing facility in Durham, North Carolina, to strengthen its U.S. manufacturing capabilities. The facility incorporates ...

President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...

Merck & Co., Inc. (MRK) said on Tuesday that it hasentered into an exclusive license agreement with China-based Jiangsu ...

MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

Medadvisor doesn’t make vaccines, but it helps vaccine makers to promote the importance of immunisation (and boost sales of ...

Make an impact by donating to the 2025 Summit silent auction, benefiting the 2025 College Aggies Online scholarship program. To make a donation, complete the request form by April 18. Previous auction ...

In July 2023, he began his clinical research career at Merck as an Emerging Talent Rotational Associate ... She began her career at Hoffmann-LaRoche in Nutley, NJ, working in drug discovery. In North ...